French pharmaceutical company Servier has partnered with Bioserenity to launch a “smart T-shirt” they’re calling the Cardioskin—a wearable innovation that would allow heart patients to monitor their cardiac rhythm throughout the day, the Daily Mail has reported.

Certain characteristics predict how responsive a blood clot will be to intravenous alteplase, according to research published Sept. 11 in JAMA—knowledge that may help clinicians more efficiently triage patients with acute ischemic stroke.

Exposure to fluoroquinolones—one of the most popular classes of antibiotics in the world—is associated with more than double the risk of aortic aneurysm or aortic dissection, according to a study published online in the Journal of the American College of Cardiology.

A peer-reviewed study published in Clinical Toxicology this week warns competitive athletes—and cardiac patients—against consuming supplements that might contain higenamine, a stimulant that’s poorly regulated and could pose a considerable threat to heart health.

Researchers at Michigan Medicine in Ann Arbor are funneling an estimated $45 million into a randomized controlled trial they hope will clarify the link between stroke and obstructive sleep apnea.

A new study out of Denmark suggests tennis and other sports with a social element are associated with the greatest improvements in life expectancy.

Late-breaking results of a trial presented at the European Society of Cardiology (ESC)’s 2018 meeting in Munich suggest a removable balloon is as effective as a permanent stent in unblocking small arteries. 

Environmental metals like arsenic, copper, cadmium and mercury could be contributing factors to cardiovascular disease—even at low levels of exposure and in developed countries, Cambridge researchers reported in the BMJ Aug. 29.